MOL Pharma

Company Description

Repaglinide demands quality, because aesthetic appeal is not the only concern, make and durability set market standards. API by MOL Pharma Private Limited are developed with finest quality raw material sourced from most renowned suppliers. Being the most reliable Repaglinide Manufacturer and Exporter we hold a reputable image, owing to a satisfied consumer base and a legal entity operating under Have Own Export License.We take pride in setting a benchmark with first in class kitchen products delivered straight away from our production facility headquartered in Beijing, Beijing, China. Generating yearly revenue estimating around US$1 Million - US$2.5 Million, based on Australia,Canada,Germany,South Korea,United Kingdom export market ratio and export value crossing Below US$1 Million. MOL Pharma was first introduced with initial business capital estimating US$10 Million, back in 2006. Now holding successful export history of around 14 Years .